Skip to main content
logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
12.69
-0.29 (-2.23%)
At close: Mar 13, 2026, 4:00 PM EDT
12.69
0.00 (0.00%)
After-hours: Mar 13, 2026, 4:10 PM EDT

Entrada Therapeutics Revenue

In the year 2025, Entrada Therapeutics had annual revenue of $25.42M, down -87.94%. Entrada Therapeutics had revenue of $1.30M in the quarter ending December 31, 2025, a decrease of -96.53%.

Revenue (ttm)
$25.42M
Revenue Growth
-87.94%
P/S Ratio
18.95
Revenue / Employee
$167,243
Employees
152
Market Cap
485.83M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202525.42M-185.36M-87.94%
Dec 31, 2024210.78M81.77M63.38%
Dec 31, 2023129.01M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Rigel Pharmaceuticals294.28M
REGENXBIO170.44M
Century Therapeutics113.34M
Aclaris Therapeutics7.83M
Upstream Bio2.80M
Altimmune41.00K
Revenue Rankings

TRDA News

More News